VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

about

Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.

P2860

Q33817641-1B5F9720-F90B-41D1-A230-1134FF447E4B

P2860

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

Item

http://www.wikidata.org/entity/Q36651022

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@ast

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@en

type

Item

label

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@ast

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@en

prefLabel

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@ast

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@en

P1476

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

@en

P2093

Grzegorz Mazur

http://www.w3.org/2001/XMLSchema#string

Justyna Dzietczenia

http://www.w3.org/2001/XMLSchema#string

Katarzyna Bogunia-Kubik

http://www.w3.org/2001/XMLSchema#string

Katarzyna Gebura

http://www.w3.org/2001/XMLSchema#string

Kazimierz Kuliczkowski

http://www.w3.org/2001/XMLSchema#string

Tomasz Wróbel

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.

Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells

The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.

Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.

The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.

Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.

The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

P2888

s12032-013-0456-4

P304

456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0456-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234703133

http://www.w3.org/2001/XMLSchema#string

P698

23335070

http://www.w3.org/2001/XMLSchema#string

P932

3586392

http://www.w3.org/2001/XMLSchema#string

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

about

P2860

P2860

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932